Skip to main content
logo
Cutia Therapeutics (HKG:2487)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.340
-0.060 (-2.50%)
Jul 31, 2026, 3:44 PM HKT

Cutia Therapeutics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
336.15336.15279.62137.6211.372.04
Revenue Growth
34.28%20.22%103.17%1110.83%457.70%-
Gross Profit
195.79195.79143.4671.017.941.61
Operating Income
-308.61-308.61-461.54-539.65-309.2-179.99
Net Income
-340.19-340.19-433.81-1,964-555.84-319.58
Earnings Per Share
-1.03-1.03-1.41-9.60-6.94-3.99
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
788.24788.24876.161,2731,0771,378
Total Debt
317.39317.39320.94243.762,6242,269
Net Cash (Debt)
470.85470.85555.221,029-1,548-891.19
Net Cash Growth
20.39%-15.20%-46.04%---
Net Cash Per Share
1.421.421.815.03-19.33-11.13

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-290.09-290.09-442.98-381.31-236.19-159.88
Capital Expenditures
-11.69-11.69-22.57-55.73-134.35-24.32
Free Cash Flow
-301.79-301.79-465.56-437.04-370.54-184.2
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.25%58.25%51.31%51.60%69.84%79.00%
Operating Margin
-91.81%-91.81%-165.06%-392.13%-2720.43%-8831.45%
Pretax Margin
-101.20%-101.20%-155.15%-1426.91%-4890.34%-15681.11%
Profit Margin
-101.20%-101.20%-155.15%-1426.91%-4890.34%-15681.11%
FCF Margin
-89.78%-89.78%-166.50%-317.56%-3260.10%-9038.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.274.417.5822.02--